How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Buy
60
MET Quote, Financials, Valuation and Earnings
Last price:
$82.75
Seasonality move
:
-0.44%
Day range:
$81.51 - $82.86
52-week range:
$64.61 - $89.05
Dividend yield:
2.6%
P/E ratio:
16.68x
P/S ratio:
0.85x
P/B ratio:
1.86x
Volume:
1.5M
Avg. volume:
3.4M
1-year change:
24.92%
Market cap:
$57.3B
Revenue:
$66.4B
EPS (TTM):
$4.96
Analysts' Opinion
-
Consensus RatingMetLife has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $92.54, MetLife has an estimated upside of 11.83% from its current price of $82.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $68.00 representing 17.83% downside risk from its current price of $82.75.
Fair Value
-
According to the consensus of 9 analysts, MetLife has 11.83% upside to fair value with a price target of $92.54 per share.
MET vs. S&P 500
-
Over the past 5 trading days, MetLife has overperformed the S&P 500 by 3.17% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MetLife does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MetLife has grown year-over-year revenues for 4 quarters straight. In the most recent quarter MetLife reported revenues of $18.3B.
Earnings Growth
-
MetLife has grown year-over-year earnings for 3 quarters straight. In the most recent quarter MetLife reported earnings per share of $1.81.
Enterprise value:
-243.7B
EV / Invested capital:
-4.87x
Price / LTM sales:
0.85x
EV / EBIT:
-39.13x
EV / Revenue:
-3.45x
PEG ratio (5yr expected):
0.20x
EV / Free cash flow:
-16.07x
Price / Operating cash flow:
3.94x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.55%
Net Income Margin (TTM):
5.32%
Return On Equity:
13.1%
Return On Invested Capital:
7.91%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $68.8B | $63.1B | $70.7B | $15.7B | $18.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $5.73 | $2.72 | $4.96 | $0.56 | $1.81 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $402.8B | $385B | $316.1B | $311.4B | $351.9B | |
| Total Assets | $780.5B | $761.7B | $650.1B | $652.1B | $705B | |
| Current Liabilities | $1.6B | $974M | $612M | $601M | $785M | |
| Total Liabilities | $706.9B | $692.3B | $624.8B | $626.2B | $673.8B | |
| Total Equity | $73.6B | $69.3B | $25.3B | $25.9B | $31.2B | |
| Total Debt | $18B | $17.5B | $17.9B | $18.8B | $18.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $15.8B | $10.8B | $15.2B | $3.5B | $4.2B | |
| Cash From Investing | -$5.3B | -$11B | -$5.6B | -$3B | -$2.2B | |
| Cash From Financing | -$6.6B | -$7.2B | -$2.8B | -$848M | -$1.1B | |
| Free Cash Flow | $15.8B | $10.8B | $15.2B | $3.5B | $4.2B | |
MET
Sector
Market Cap
$57.3B
$700.3M
Price % of 52-Week High
92.93%
88.31%
Dividend Yield
2.6%
2.2%
Shareholder Yield
8.65%
3.87%
1-Year Price Total Return
24.93%
7.75%
Beta (5-Year)
1.065
0.737
Dividend yield:
2.6%
Annualized payout:
$2.06
Payout ratio:
46.15%
Growth streak:
11 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$81.37
200-day SMA
Buy
Level
$76.10
Bollinger Bands (100)
Buy
Level
75.13 - 85.09
Chaikin Money Flow
Buy
Level
786.5M
20-day SMA
Sell
Level
$83.35
Relative Strength Index (RSI14)
Sell
Level
50.00
ADX Line
Buy
Level
25.65
Williams %R
Neutral
Level
-48.2005
50-day SMA
Sell
Level
$83.18
MACD (12, 26)
Sell
Level
-0.59
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
660.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8255)
Sell
CA Score
(Annual)
Level (-2.4979)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.2736)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MetLife is one of the largest life insurers in the us by assets and provides a variety of insurance and financial-services products. It is organized into five segments: us, Asia, Latin America, Europe/Middle East/Africa, and MetLife Holdings. The us business contributes around 50% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 22% of earnings and is mainly composed of the Japan business, with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of earnings. The EMEA and MetLife Holdings segments contribute around 4% and 11% of earnings, respectively.
Stock Forecast FAQ
In the current month, MET has received 7 Buy ratings 2 Hold ratings, and 0 Sell ratings. The MET average analyst price target in the past 3 months is $92.54.
-
Where Will MetLife Stock Be In 1 Year?
According to analysts, the consensus estimate is that MetLife share price will rise to $92.54 per share over the next 12 months.
-
What Do Analysts Say About MetLife?
Analysts are divided on their view about MetLife share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MetLife is a Sell and believe this share price will drop from its current level to $68.00.
-
What Is MetLife's Price Target?
The price target for MetLife over the next 1-year time period is forecast to be $92.54 according to 9 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is MET A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MetLife is a Buy. 7 of 9 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MET?
You can purchase shares of MetLife via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MetLife shares.
-
What Is The MetLife Share Price Today?
MetLife was last trading at $82.75 per share. This represents the most recent stock quote for MetLife. Yesterday, MetLife closed at $82.75 per share.
-
How To Buy MetLife Stock Online?
In order to purchase MetLife stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
